scispace - formally typeset
L

Lori C. Jordan

Researcher at Vanderbilt University Medical Center

Publications -  210
Citations -  16498

Lori C. Jordan is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Stroke & Pediatric stroke. The author has an hindex of 38, co-authored 186 publications receiving 11933 citations. Previous affiliations of Lori C. Jordan include Veterans Health Administration & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

Safety of 3 Tesla Magnetic Resonance Imaging in Patients with Sickle Cell Disease.

TL;DR: In this paper, the authors performed MRI at the clinical field strength of 3 T in 172 patients with SCD, which included standard anatomical and angiographic assessments together with gold standard diffusion-weighted imaging (DWI) for acute infarct assessment.
Journal Article

Abstract T P371: Utility of Cerebral Oximetry with Cerebral Blood Volume Index (CBVI) in Detecting Pediatric Strokes

TL;DR: Cerebral Oximetry with CBVI has potential for expediting stroke recognition and decreasing imaging time and has shown its’ potential as an objective screening tool for identify pediatric strokes and types.
Journal ArticleDOI

Primary Prevention of Strokes in Nigerian Children with Sickle Cell Disease (SPIN Trial): Final Results

TL;DR: The hypothesis that moderate fixed dose of hydroxyurea (20 mg/kg/day) for primary stroke prevention was feasible in a low-income setting, Kano, Nigeria was tested and found a statistically significant higher incidence rate of pain in the comparison group, which was significantly lower than the reported rate of stroke in the standard care group for the STOP study.
Journal ArticleDOI

Pediatric Stroke, Health Disparities, and Biological Differences in Disease Pathophysiology

TL;DR: Lehman et al. as mentioned in this paper used administrative death certificate data from the National Center for Health Statistics to show indirectly that the racial disparity in ischemic strokedeath rates inUSchildren seems tohave improved after the landmark StrokePreventionTrial inSickleCell Anemia (STOP).